InvestorsHub Logo
Followers 1
Posts 45
Boards Moderated 0
Alias Born 07/15/2006

Re: None

Monday, 10/02/2006 10:48:07 PM

Monday, October 02, 2006 10:48:07 PM

Post# of 7730
"In July 2005, Geron chief executive Tom Okarma declared that his Menlo Park, Calif., company planned to begin clinical trials using embryonic stem cells to treat acute spinal cord injury within the year. Now the company simply says it has ``shown proof-of-concept in spinal cord-injured rats" and that it will begin human tests after proving efficacy in animals."

http://www.boston.com/news/globe/editorial_opinion/oped/articles/2006/10/01/hope_unfulfilled_promise...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GERN News